Spero R. Cataland, MD
Dr. Spero Cataland is a Professor of Internal Medicine in the Division of Hematology at the Wexner
Medical Center at The Ohio State University. He is also the Director of the Benign Hematology Program
at Ohio State University. Dr. Cataland received his medical degree from Ohio State University College of
Medicine and completed his residency at Ohio State University Hospital, after which he went on to
complete fellowship training in hematology/oncology at the University of Chicago Medical Center. After
completing his training in hematology he returned to Ohio State University where he presently remains
on the faculty.
Dr. Cataland's clinical and research interests include thrombotic thrombocytopenic purpura (TTP) and
atypical hemolytic uremic syndrome (aHUS) with an emphasis on immune-mediated TTP (iTTP). Dr.
Cataland directs the Biomarker Reference Laboratory at Ohio State University which performs
correlative laboratory studies for ongoing research. Dr. Cataland has a long-standing interest in the
development of long-term complications in patients with a prior history of TTP and the mechanisms for
their development. Dr. Cataland has also worked to establish the United States Thrombotic
Microangiopathy Clinical Consortium, an organization of over 15 academic medical centers that was
organized to conduct collaborative research in TTP and aHUS.